Biorestorative TherapiesBRTX

13F holders, Q4 2025 (December 31)
13holders −1
2new positions
4sold out
1famous investor
$1.17avg. 13F price*

At the end of Q4 2025, 13 institutions reported holding Biorestorative Therapies Inc. (BRTX) in their 13F filings, down 1 from Q3 2025. 2 opened new positions and 4 sold out. The largest holders were Vanguard Group Inc. ($104K), Geode Capital Management, LLC ($68K) and DRW Securities, LLC ($55K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Biorestorative Therapies Inc.
CUSIP
090655606
Latest filing quarter
Q2 2026

History

Number of 13F holders

0510152025 Q1 2024: 13Q1 2024Q2 2024: 13Q2 2024Q3 2024: 15Q3 2024Q4 2024: 15Q4 2024Q1 2025: 14Q1 2025Q2 2025: 15Q2 2025Q3 2025: 14Q3 2025Q4 2025: 13Q4 2025Q1 2026: 11Q1 2026Q2 2026: 21Q2 2026

Total Exit/New Position Q3 2025 → Q4 2025

InstitutionsTotal Value
New Positions2$69K
Exits4$91K

All 13F filers, Q3 2025 → Q4 2025: 73,051 shares bought and 142,520 shares sold, net −69,469 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 13 holders

Vanguard Group Inc. 0.00% No change 88,778 $104K
Geode Capital Management, LLC 0.00% Add +4.7% 57,854 $68K
DRW Securities, LLC 0.00% New 46,665 $55K
Wealth Alliance, LLC 0.00% No change 40,000 $47K
State Street Corp. 0.00% Add +58.6% 32,459 $38K
Citadel Advisors 0.00% Reduce -72.5% 29,198 $34K
Napier Financial, LLC 0.01% — 17,142 $20K
Two Sigma Securities, LLC 0.00% New 11,777 $14K
Osaic Holdings, Inc. 0.00% Reduce -8.8% 2,000 $2K
Tower Research Capital LLC (TRC) 0.00% Reduce -69.4% 1,106 $1K
SBI Securities Co., Ltd. 0.00% Add +13.3% 119 $140
Bank of America Corp. 0.00% Add +20.0% 60 $71
TD Waterhouse Canada Inc. 0.00% No change 3 $3

"% of holder's portfolio" is BRTX's weight in each manager's 13F, not the share of Biorestorative Therapies Inc. the manager owns.